Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Fourquet

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 15, 1995
Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiationM Maher, F Campana, V Mosseri, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 6, 2004
[Histological margin and residual disease assessment for breast carcinoma]B Sigal-Zafrani, A Fourquet, A Vincent-Salomon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 6, 2021
Dosimetric comparison of four high performance techniques for irradiation of breast cancer patientsL Bartolucci, C Adrien, F Goudjil, et al.
Bulletin Du Cancer|August 1, 1994
[Superoxide dismutase (Cu/Zn) in cutaneous application in the treatment of radiation-induced fibrosis]B Perdereau, F Campana, J R Vilcoq, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term resultsB Zafrani, P Vielh, A Fourquet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1989
Presentation of axillary lymphadenopathy without detectable breast primary (T0 N1b breast cancer): experience at Institut CurieF Campana, A Fourquet, M A Ashby, et al.
Cytometry|July 13, 2001
Comparative image and flow cytometric TUNEL analysis of fine needle samples of breast carcinomaZ Maciorowski, J Klijanienko, E Padoy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1996
Metachronous contralateral breast cancer as first event of relapseA de la Rochefordière, E Mouret-Fourme, B Asselain, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 12, 2010
Delayed reaction after adjuvant whole breast radiotherapy at the dose of 42.9 Gy in 13 fractions over 5 weeks: the need for rapid post irradiation clinical assessment and who are the patients at risk?Y M Kirova, M Botti, F Campana, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 27, 2021
[Concurrent radiation therapy and dual HER2 blockade in breast cancer: Assessment of toxicity]S Ben Dhia, P Loap, D Loirat, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
International Journal of Radiation Oncology, Biology, Physics|February 15, 1995
Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiationM Maher, F Campana, V Mosseri, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 6, 2004
[Histological margin and residual disease assessment for breast carcinoma]B Sigal-Zafrani, A Fourquet, A Vincent-Salomon, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 6, 2021
Dosimetric comparison of four high performance techniques for irradiation of breast cancer patientsL Bartolucci, C Adrien, F Goudjil, et al.
Bulletin Du Cancer|August 1, 1994
[Superoxide dismutase (Cu/Zn) in cutaneous application in the treatment of radiation-induced fibrosis]B Perdereau, F Campana, J R Vilcoq, et al.
European Journal of Cancer & Clinical Oncology|November 1, 1989
Conservative treatment of early breast cancer: prognostic value of the ductal in situ component and other pathological variables on local control and survival. Long-term resultsB Zafrani, P Vielh, A Fourquet, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 1, 1989
Presentation of axillary lymphadenopathy without detectable breast primary (T0 N1b breast cancer): experience at Institut CurieF Campana, A Fourquet, M A Ashby, et al.
Cytometry|July 13, 2001
Comparative image and flow cytometric TUNEL analysis of fine needle samples of breast carcinomaZ Maciorowski, J Klijanienko, E Padoy, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1996
Metachronous contralateral breast cancer as first event of relapseA de la Rochefordière, E Mouret-Fourme, B Asselain, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|February 12, 2010
Delayed reaction after adjuvant whole breast radiotherapy at the dose of 42.9 Gy in 13 fractions over 5 weeks: the need for rapid post irradiation clinical assessment and who are the patients at risk?Y M Kirova, M Botti, F Campana, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|March 27, 2021
[Concurrent radiation therapy and dual HER2 blockade in breast cancer: Assessment of toxicity]S Ben Dhia, P Loap, D Loirat, et al.
Pageof 17